Stevanato Group S.p.A. (STVN)

Price$18.46

Value ScoreC

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-28.90%

Price vs S&P 500 (4W)1.27%

VGM Score47.72

Market Capitalization$5.83B

P/E Ratio (Annual)31.27x

Indicated Dividend Yield (Annual)0.33%

All Metrics

P/CF (Annual)15.29x

Book Value / Share (Quarterly)$6.48

P/TBV (Annual)3.29x

Indicated Dividend (Annual)$0.07

Revenue Growth (3Y)6.44%

Cash Flow / Share (Quarterly)$-0.05

Payout Ratio (TTM)18.07%

Price vs S&P 500 (YTD)-16.41%

Gross Margin (TTM)29.73%

Net Profit Margin (TTM)11.75%

EPS (TTM)$0.60

10-Day Avg Trading Volume0.25M

EPS Excl Extra (TTM)$0.60

Revenue Growth (5Y)12.37%

EPS (Annual)$0.59

Dividend / Share (Annual)$0.06

ROI (Annual)7.15%

Gross Margin (Annual)29.60%

Net Profit Margin (5Y Avg)13.26%

Cash / Share (Quarterly)$0.52

P/E Basic Excl Extra (TTM)30.94x

Revenue Growth QoQ (YoY)6.62%

EPS Growth (5Y)13.98%

P/E Normalized (Annual)31.27x

ROA (Last FY)5.50%

Revenue Growth TTM (YoY)6.99%

EBITD / Share (TTM)$0.91

ROE (5Y Avg)12.19%

Operating Margin (TTM)16.86%

Cash Flow / Share (Annual)$0.05

P/B Ratio2.86x

P/B Ratio (Quarterly)2.36x

Net Income / Employee (Annual)$26,946

EV / Revenue (TTM)3.91x

Net Interest Coverage (TTM)20.90x

ROA (TTM)5.72%

EPS Growth QoQ (YoY)5.66%

EV / EBITDA (TTM)21.88x

EPS Incl Extra (Annual)$0.59

Current Ratio (Annual)1.76x

Quick Ratio (Quarterly)1.11x

3-Month Avg Trading Volume0.59M

52-Week Price Return-20.57%

EV / Free Cash Flow (Annual)426.46x

P/E Incl Extra (TTM)30.94x

Revenue / Employee (TTM)$231,530

Tangible BV / Share (Quarterly)$6.33

P/S Ratio (Annual)3.69x

Asset Turnover (Annual)0.47x

52-Week High$28.00

Operating Margin (5Y Avg)17.73%

EPS Excl Extra (Annual)$0.59

CapEx CAGR (5Y)23.43%

26-Week Price Return-20.98%

Quick Ratio (Annual)1.26x

13-Week Price Return16.03%

Total Debt / Equity (Annual)0.32x

Current Ratio (Quarterly)1.63x

Enterprise Value$5.45B

Revenue / Share Growth (5Y)14.12%

Asset Turnover (TTM)0.49x

Revenue / Employee (Annual)$228,292

Inventory Turnover (Annual)3.25x

Pretax Margin (Annual)15.94%

Cash / Share (Annual)$0.55

3-Month Return Std Dev40.38%

Gross Margin (5Y Avg)31.00%

Net Income / Employee (TTM)$27,178

EBITDA CAGR (5Y)13.56%

EBITDA Interim CAGR (5Y)-1.22%

ROE (Last FY)9.41%

Net Interest Coverage (Annual)16.31x

EPS Basic Excl Extra (Annual)$0.59

P/FCF (TTM)916.86x

Receivables Turnover (TTM)2.76x

EV / Free Cash Flow (TTM)412.96x

Total Debt / Equity (Quarterly)0.29x

EPS Incl Extra (TTM)$0.60

Receivables Turnover (Annual)2.44x

ROI (TTM)7.41%

P/S Ratio (TTM)3.63x

Pretax Margin (5Y Avg)17.33%

Revenue / Share (Annual)$5.03

Tangible BV / Share (Annual)$6.14

Forward P/E24.46x

Free OCF CAGR (5Y)-28.64%

Price vs S&P 500 (52W)-44.93%

P/E Ratio (TTM)30.94x

EPS Growth TTM (YoY)12.61%

Year-to-Date Return-8.25%

5-Day Price Return-2.17%

EPS Normalized (Annual)$0.59

ROA (5Y Avg)7.13%

Net Profit Margin (Annual)11.79%

Month-to-Date Return-1.07%

Cash Flow / Share (TTM)$1.04

EBITD / Share (Annual)$0.90

EPS Growth (3Y)-1.71%

Operating Margin (Annual)16.76%

LT Debt / Equity (Annual)0.23x

P/CF (TTM)16.71x

ROI (5Y Avg)8.81%

P/E Excl Extra (TTM)30.94x

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$0.60

P/TBV (Quarterly)2.42x

Payout Ratio (Annual)10.54%

P/B Ratio (Annual)3.21x

Dividend / Share (TTM)$0.06

Inventory Turnover (TTM)3.04x

Pretax Margin (TTM)16.06%

Book Value / Share (Annual)$6.30

Price vs S&P 500 (13W)7.77%

Net Margin Growth (5Y)-0.12%

Dividend Yield (TTM)0.34%

Beta0.75x

P/FCF (Annual)395.96x

Revenue / Share (TTM)$5.10

ROE (TTM)9.66%

52-Week Low$12.89

vGradeC

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.13est. 0.12

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.18

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
STVNStevanato Group S.p.A.	C	C	C	$18.46
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

Stevanato Group provides integrated drug containment, delivery, and diagnostic solutions throughout the pharmaceutical and biotechnology industries' product life cycles, spanning development, clinical, and commercial stages. The company operates through two segments: Biopharmaceutical and Diagnostic Solutions, which generates the majority of revenue, and Engineering. Stevanato derives most of its revenue from Europe, the Middle East, and Africa.